Skip to main content
Premium Trial:

Request an Annual Quote

Microbial Existentialism

If a researcher takes a swab of your nose and finds a new species of bacteria, the discovery of which leads to the development of a new drug, do you deserve a cut of those profits, asks Carl Zimmer in The New York Times. More and more, bioethicists are asking questions about people's relationships with their microbiomes, Zimmer says. Mount Sinai School of Medicine bioethicist Rosamond Rhodes tells Zimmer that information on an individual's microbiome deserves the same protection of privacy as genetic information.

But granting a person's microbiome the same protection as their genetic information could prove tricky. "Microbes defy a simple notion of individuality. They are essential to our biology, and they travel with us from birth to death. Yet they also flow between us, and can be found in water, food and soil," Zimmer says. For right now, the most important thing, researchers say, is to be honest with participants involved in microbiome studies to make sure they have a realistic understanding about any research they're taking part in. However, Zimmer adds, if new drugs start emerging from the insights provided by these studies, it may be time to consider how the study participants can share in the benefits.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.